Multiple Sclerosis
Search for publications
Only original articles, editorials, guidelines.
-
Gil-Varea, Elia, Fedetz, Maria, Eixarch, Herena, Spataro, Nino, Villar, Luisa Maria, Urcelay, Elena, Saiz, Albert, Fernandez, Oscar, Leyva, Laura, Ramio-Torrenta, Lluis, Vandenbroeck, Koen, Otaegui, David, Castillo-Trivino, Tamara, Izquierdo, Guillermo, Malhotra, Sunny, Bosch, Elena, Navarro, Arcadi, Alcina, Antonio, Montalban, Xavier, Matesanz, Fuencisla, Comabella, Manuel.
A New Risk Variant for Multiple Sclerosis at 11q23.3 Locus Is Associated with Expansion of CXCR5+ Circulating Regulatory T Cells
Journal Of Clinical Medicine . 9(3): . Number of citations: 5
-
Martínez-García MÁ, Ojeda-Ojeda, Miriam, Rodriguez-Martin, Eulalia, Insenser, Maria, Moncayo, Samuel, Alvarez-Blasco, Francisco, Luque-Ramirez, Manuel, Escobar-Morreale, Hector F..
TLR2 and TLR4 Surface and Gene Expression in White Blood Cells after Fasting and Oral Glucose, Lipid and Protein Challenges: Influence of Obesity and Sex Hormones
Biomolecules . 10(1): . Number of citations: 16
-
Mariscal-Rodríguez A, Villar Guimerans LM, López-Trascasa M, Hernández González M, Moga Naranjo E.
Laboratory guidelines for the diagnosis of patients with cryoglobulinaemic syndrome.
REVISTA CLINICA ESPANOLA . 219(9): 505-513.
-
Muñoz-San Martín M, Reverter G, Robles-Cedeño R, Buxò M, Ortega FJ, Gómez I, Tomàs-Roig J, Celarain N, Villar LM, Perkal H, Fernández-Real JM, Quintana E, Ramió-Torrentà L.
Analysis of miRNA signatures in CSF identifies upregulation of miR-21 and miR-146a/b in patients with multiple sclerosis and active lesions.
JOURNAL OF NEUROINFLAMMATION . 16(1): 220-220. Number of citations: 28
-
Alonso-Canovas A, Tembl Ferrairó JI, Martínez-Torres I, Lopez-Sendon Moreno JL, Parees-Moreno I, Monreal-Laguillo E, Pérez-Torre P, Toledano Delgado R, García Ribas G, Sastre Bataller I, Masjuan J, Martinez-Castrillo JC, Walter U.
Transcranial sonography in atypical parkinsonism: How reliable is it in real clinical practice? A multicentre comprehensive study.
PARKINSONISM & RELATED DISORDERS . 68: 40-45. Number of citations: 9
-
Moreira A, Alari-Pahissa E, Munteis E, Vera A, Zabalza A, Llop M, Villarrubia N, Costa-García M, Álvarez-Lafuente R, Villar LM, López-Botet M, Martínez-Rodríguez JE.
Adaptive Features of Natural Killer Cells in Multiple Sclerosis.
Frontiers in immunology . 10: 2403-2403. Number of citations: 13
-
Fissolo N, Cervera-Carles L, Villar Guimerans LM, Lleó A, Clarimón J, Drulovic J, Dujmovic I, Voortman M, Khalil M, Gil E, Navarro L, Álvarez-Cermeño JC, Montalban X, Comabella M.
Cerebrospinal fluid mitochondrial DNA levels in patients with multiple sclerosis.
MULTIPLE SCLEROSIS JOURNAL . 25(11): 1535-1538. Number of citations: 3
-
Fraussen J, Marquez S, Takata K, Beckers L, Montes Diaz G, Zografou C, Van Wijmeersch B, Villar LM, O'Connor KC, Kleinstein SH, Somers V.
Phenotypic and Ig Repertoire Analyses Indicate a Common Origin of IgD - CD27 - Double Negative B Cells in Healthy Individuals and Multiple Sclerosis Patients.
JOURNAL OF IMMUNOLOGY . 203(6): 1650-1664. Number of citations: 16
-
Cuello JP, Martínez Ginés ML, Kuhle J, García Domínguez JM, Lozano Ros A, Romero Delgado F, Higueras Y, Meldaña Rivera A, Goicochea Briceño H, García-Tizon Larroca S, de-León Ruiz J, Michalak Z, Barro C, Álvarez Lafuente R, Medina Heras S, Fernández Velasco JI, Tejeda-Velarde A, Domínguez-Mozo MI, Muriel A, de Andrés C, Villar LM.
Neurofilament light chain levels in pregnant multiple sclerosis patients: a prospective cohort study.
EUROPEAN JOURNAL OF NEUROLOGY . 26(9): 1200-1204. Number of citations: 11
-
Mestre L, Carrillo-Salinas FJ, Mecha M, Feliú A, Espejo C, Álvarez-Cermeño JC, Villar LM, Guaza C.
Manipulation of Gut Microbiota Influences Immune Responses, Axon Preservation, and Motor Disability in a Model of Progressive Multiple Sclerosis.
Frontiers in immunology . 10: 1374-1374. Number of citations: 23
-
Fernandez O, Tintore M, Saiz A, Calles-Hernandez MC, Comabella M, Ramio-Torrenta L, Oterino A, Izquierdo G, Tellez N, Garcia-Merino JA, Brieva L, Arnal-Garcia C, Aladro Y, Mendibe-Bilbao MM, Meca-Lallana JE, Romero-Pinel L, Martinez-Gines ML, Arroyo R, Oreja-Guevara C, Costa-Frossard L, Carrascal P, Rodriguez-Antiguedad A.
Review of the novelties presented at the 2018 ECTRIMS Congress: 11th Post-ECTRIMS Meeting (II).
REVISTA DE NEUROLOGIA . 68(11): 468-479.
-
van Rossum JA, Killestein J, Villar LM, Riskind PN, Freedman MS, Teunissen C.
gMS-Classifier1 does not predict disability progression in multiple sclerosis.
MULTIPLE SCLEROSIS JOURNAL . 25(7): 1010-1011.
-
Pérez-Miralles F, Prefasi D, García-Merino A, Ara JR, Izquierdo G, Meca-Lallana V, Gascón F, Martínez-Ginés ML, Ramió-Torrentà L, Costa-Frossard L, Fernández Ó, Moreno-García S, Maurino J, Casanova-Estruch B.
Perception of stigma in patients with primary progressive multiple sclerosis.
MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL . 5(2): . Number of citations: 5
-
Sainz de la Maza S, Medina S, Villarrubia N, Costa-Frossard L, Monreal E, Tejeda-Velarde A, Rodríguez-Martín E, Roldán E, Álvarez-Cermeño JC, Villar LM.
Factors associated with dimethyl fumarate-induced lymphopenia.
JOURNAL OF THE NEUROLOGICAL SCIENCES . 398: 4-8. Number of citations: 19
-
Medina S, Sainz de la Maza S, Villarrubia N, Álvarez-Lafuente R, Costa-Frossard L, Arroyo R, Monreal E, Tejeda-Velarde A, Rodríguez-Martín E, Roldán E, Álvarez-Cermeño JC, Villar LM.
Teriflunomide induces a tolerogenic bias in blood immune cells of MS patients.
Annals of Clinical and Translational Neurology . 6(2): 355-363. Number of citations: 10
-
Tejeda Velarde, Amalia, Medina Heras, Silvia, Villar Guimerans, Luisa Maria.
Biomarkers for Multiple Sclerosis
RSC Drug Discovery Series . 70: 55-75.
-
Villarrubia N, Rodríguez-Martín E, Alari-Pahissa E, Aragón L, Castillo-Triviño T, Eixarch H, Ferrer JM, Martínez-Rodríguez JE, Massot M, Pinto-Medel MJ, Prada Á, Rodríguez-Acevedo B, Urbaneja P, Gascón-Gimenez F, Herrera G, Hernández-Clares R, Salgado MG, Oterino A, Segundo DS, Cuello JP, Gil-Herrera J, Cámara C, Gómez-Gutiérrez M, Martínez-Hernández E, Meca-Lallana V, Moga E, Muñoz-Calleja C, Querol L, Presas-Rodríguez S, Teniente-Serra A, Vlagea A, Muriel A, Roldán E, Villar LM.
Multi-centre validation of a flow cytometry method to identify optimal responders to interferon-beta in multiple sclerosis.
CLINICA CHIMICA ACTA . 488: 135-142. Number of citations: 1
-
Malhotra S, Villar LM, Costa C, Midaglia L, Cubedo M, Medina S, Fissolo N, Río J, Castilló J, Álvarez-Cermeño JC, Sánchez A, Montalban X, Comabella M.
Circulating EZH2-positive T cells are decreased in multiple sclerosis patients.
JOURNAL OF NEUROINFLAMMATION . 15(1): 296-296. Number of citations: 5